The CD39 molecule is a surface ectonucleotidase involved in the creation of an antiinflammatory microenvironment and has been described as a marker for tumor‐specific CD4 and CD8 TILs.21, 43, 44. This evidence concerns the gene ENTPD1 and neoplasm.